I don't know where they are from.
I also don't know what contractual conditions might exists perhaps between CYP and others that are managing the trial in different countries or in particular sites within a country constraining what they can say.
Like you, I'd be interested to hear when a first patient is treated in the US, but I'm not sure that that is going to happen.
Ann: Investor Presentation, page-291
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.68M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 22.5¢ | $30.97K | 137.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8412 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 16723 | 1 |
View Market Depth
| Last trade - 13.24pm 19/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |